12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · 03/26 21:05
Gainers
- Vyome Holdings (NASDAQ:HIND) shares rose 11.3% to $2.45 during Thursday's after-market session. The company's market cap stands at $15.9 million.
- Tiziana Life Sciences (NASDAQ:TLSA) stock moved upwards by 11.19% to $1.39. The market value of their outstanding shares is at $171.7 million.
- Lunai Bioworks (NASDAQ:LNAI) stock increased by 10.69% to $0.55. The market value of their outstanding shares is at $9.7 million.
- SIGA Technologies (NASDAQ:SIGA) shares moved upwards by 10.38% to $5.47. The company's market cap stands at $356.4 million.
- Alpha Cognition (NASDAQ:ACOG) stock moved upwards by 10.11% to $5.88. The company's market cap stands at $115.6 million. The company's, Q4 earnings came out today.
- Reviva Pharmaceuticals (NASDAQ:RVPH) stock increased by 6.5% to $0.83. The market value of their outstanding shares is at $10.5 million.
Losers
- Precision Optics Corp (NASDAQ:POCI) stock declined by 14.5% to $3.6 during Thursday's after-market session. The market value of their outstanding shares is at $34.6 million.
- Modular Medical (NASDAQ:MODD) shares decreased by 13.8% to $0.15. The company's market cap stands at $26.1 million.
- Zenas BioPharma (NASDAQ:ZBIO) stock decreased by 9.75% to $20.0. The company's market cap stands at $1.2 billion.
- Eupraxia Pharmaceuticals (NASDAQ:EPRX) shares declined by 8.91% to $6.24. The company's market cap stands at $435.4 million.
- Firefly Neuroscience (NASDAQ:AIFF) stock decreased by 8.28% to $2.77. The market value of their outstanding shares is at $26.3 million.
- Radiopharm Theranostics (NASDAQ:RADX) shares declined by 7.77% to $3.92. The company's market cap stands at $33.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.